Price movement over the last 24 hours
ARK Genomic Revolution ETF vs Valero Energy Corporation — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while Valero Energy Corporation trades at $285.35 (market cap $83.35B). The key difference: Valero Energy Corporation pays a 1.71% dividend while ARK Genomic Revolution ETF pays none, and Valero Energy Corporation is trading nearer its 52-week high, ARK Genomic Revolution ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | VLO | |
|---|---|---|
Sector | Sector/Thematic | Energy |
52-Week High | $43.57 | $282.88 |
52-Week Low | $23.09 | $131.77 |
Market Cap | — | $83.35B |
Enterprise Value | — | $89.10B |
Dividend Yield | — | 1.71% |
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Valero Energy (VLO) trades at $280.69, down 0.2% on the day, with strong technical momentum as the stock approaches resistance near $285. The company has consistently beaten earnings estimates for three consecutive quarters, with Q2 2026 expected at $10.03 EPS. Fundamentals show solid profitability with 17.72% ROE and improving cash flow projections for 2026. Recent news highlights strong refining margins and Gulf Coast operational advantages supporting the bullish outlook.
VLO presents a compelling investment case with strong earnings momentum and favorable industry dynamics, though investors face risks from energy market volatility and declining revenue trends. The stock trades above the consensus price target of $257.57, suggesting limited near-term upside despite 58% analyst buy ratings. The upcoming dividend payment of $1.20 provides additional shareholder return potential.
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →Valero Energy is one of the largest independent refiners in the United States. It operates 14 refineries with a total throughput capacity of 3.2 million barrels a day in the United States, Canada, and the United Kingdom. Valero also owns 14 ethanol plants with capacity of 1.7 billion gallons of ethanol a year and holds a 50% stake in Diamond Green Diesel, which has capacity to produce 700 million gallons per year of renewable diesel.
Read more on VLO →